adenosine monophosphate has been researched along with Tachyarrhythmia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, HT; Glaberson, WR; Leeman, R; Mahajan, N; Manalo, R | 1 |
| Hintze, T; Jacobson, KA; Kumar, TS; Liang, BT; Mamdani, M; Pappano, AJ; Qanud, K; Recchia, FA; Shen, JB; Zhou, SY | 1 |
| Bukowska, A; Dudley, SC; Gardemann, A; Goette, A; Keilhoff, G; Klein, HU; Lendeckel, U; Polczyk, P; Schild, L; Täger, M | 1 |
3 other study(ies) available for adenosine monophosphate and Tachyarrhythmia
| Article | Year |
|---|---|
Case of multisystem inflammatory syndrome in children presenting as fever and abdominal pain.
Topics: Abdominal Pain; Adenosine Monophosphate; Alanine; C-Reactive Protein; Child; COVID-19; COVID-19 Drug Treatment; COVID-19 Nucleic Acid Testing; COVID-19 Serological Testing; Diagnosis, Differential; Fever; Humans; Interleukin 1 Receptor Antagonist Protein; Intubation, Intratracheal; Male; Mucocutaneous Lymph Node Syndrome; Myocarditis; Nasopharynx; Natriuretic Peptide, Brain; SARS-CoV-2; Systemic Inflammatory Response Syndrome; Tachycardia; Treatment Outcome | 2020 |
Treatment of heart failure by a methanocarba derivative of adenosine monophosphate: implication for a role of cardiac purinergic P2X receptors.
Topics: Adenosine Monophosphate; Animals; Cardiac Pacing, Artificial; Cardiomyopathy, Dilated; Dogs; Heart; Heart Failure; Heart Function Tests; Hemodynamics; Infusions, Intravenous; Male; Mice; Mice, Transgenic; Myocardial Contraction; Myocardium; Receptors, Purinergic P2; Tachycardia; Ultrasonography; Ventricular Function, Left | 2010 |
Rapid pacing of embryoid bodies impairs mitochondrial ATP synthesis by a calcium-dependent mechanism--a model of in vitro differentiated cardiomyocytes to study molecular effects of tachycardia.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Calcium; Cardiac Pacing, Artificial; Cell Differentiation; Cell Respiration; Energy Metabolism; Enzyme Activation; Gene Expression Regulation, Enzymologic; Hypertrophy; Mice; Mitochondria; Mitogen-Activated Protein Kinase 1; Myocytes, Cardiac; Oxidative Stress; RNA, Messenger; Sulfhydryl Compounds; Tachycardia; Verapamil | 2006 |